What’s the current market cap for Accendra Health stock?

Accendra Health (ACH) has a market cap of $217M as of May 25, 2026.

What is the P/E ratio for Accendra Health stock?

The price to earnings (P/E) ratio for Accendra Health (ACH) stock is 0 as of May 25, 2026.

Does Accendra Health stock pay dividends?

No, Accendra Health (ACH) stock does not pay dividends to its shareholders as of May 25, 2026.

When is the next Accendra Health dividend payment date?

Accendra Health (ACH) stock does not pay dividends to its shareholders.

What is the beta indicator for Accendra Health?

Accendra Health (ACH) has a beta rating of 1.7. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy Accendra Health stock | $ACH Share Price

About Accendra Health

Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions.

Ticker

$ACH

Sector

Health

Primary listing

NYSE

Employees

6,500

Headquarters

Glen Allen, United States

Website

www.accendrahealth.com

Accendra Health Metrics

BasicAdvanced

$217m

-

-$14.11

1.70

-

What the Analysts think about Accendra Health

Analyst ratings (Buy, Hold, Sell) for Accendra Health stock.

Accendra Health Financial Performance

Revenues and expenses

QuarterlyAnnual

Q3 24

QoQ growth

Revenue

$37bn

-39.75%

Net income

$45bn

107.52%

Profit margin

37.65%

6.78%

Accendra Health Earnings Performance

Company profitability

QuarterlyAnnual

Q4 23

Q1 24

Q2 24

Q3 24

Q4 24

Actual

$3.69

$2.85

$2.45

$2.42

-

Expected

$3.55

$2.61

$2.05

$2.31

$3.94

Surprise

3.94%

9.20%

19.51%

4.63%

-

Accendra Health News

AllArticlesVideos

Accendra Health Announces Offers and Consent Solicitations

Business Wire·2 days ago

Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction

Business Wire·2 weeks ago

Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call

Business Wire·3 weeks ago

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.

Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.